Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 27, 2015
Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML
Irina Sadovnik, Andrea Hoelbl-Kovacic, Harald Herrmann, et al.
Cancers
|
April 25, 2020
STAT5 is Expressed in CD34<sup>+</sup>/CD38<sup>-</sup> Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms
Emir Hadzijusufovic, Alexandra Keller, Daniela Berger, et al.
American Journal of Hematology
|
February 23, 2023
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms
Daniel Ivanov, Jelena D Milosevic Feenstra, Irina Sadovnik, et al.
Blood
|
December 24, 2023
Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis
Georg Greiner, Nadine Witzeneder, Klara Klein, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 20, 2022
Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium
Polina Pyatilova, Cem Akin, Iván Alvarez-Twose, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 12, 2023
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT
Peter Valent, Gregor Hoermann, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 27, 2022
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium
Peter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
International Journal of Cancer
|
October 9, 2020
Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer
Osman Aksoy, Jan Pencik, Markus Hartenbach, et al.
Blood
|
June 17, 2018
Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy
Edit Porpaczy, Sabrina Tripolt, Andrea Hoelbl-Kovacic, et al.
The Lancet. Haematology
|
January 28, 2021
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study
Javier I Muñoz-González, Iván Álvarez-Twose, María Jara-Acevedo, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 27, 2015
Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML
Irina Sadovnik, Andrea Hoelbl-Kovacic, Harald Herrmann, et al.
Cancers
|
April 25, 2020
STAT5 is Expressed in CD34<sup>+</sup>/CD38<sup>-</sup> Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms
Emir Hadzijusufovic, Alexandra Keller, Daniela Berger, et al.
American Journal of Hematology
|
February 23, 2023
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms
Daniel Ivanov, Jelena D Milosevic Feenstra, Irina Sadovnik, et al.
Blood
|
December 24, 2023
Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis
Georg Greiner, Nadine Witzeneder, Klara Klein, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 20, 2022
Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium
Polina Pyatilova, Cem Akin, Iván Alvarez-Twose, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 12, 2023
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT
Peter Valent, Gregor Hoermann, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 27, 2022
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium
Peter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
International Journal of Cancer
|
October 9, 2020
Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer
Osman Aksoy, Jan Pencik, Markus Hartenbach, et al.
Blood
|
June 17, 2018
Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy
Edit Porpaczy, Sabrina Tripolt, Andrea Hoelbl-Kovacic, et al.
The Lancet. Haematology
|
January 28, 2021
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study
Javier I Muñoz-González, Iván Álvarez-Twose, María Jara-Acevedo, et al.
Page
of 6